Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis

Nguyen, Nam NhatNam NhatNguyenHo, Dung SiDung SiHoNguyen, Hung SongHung SongNguyenHo, Dang Khanh NganDang Khanh NganHoHUNG-YUAN LILin, Chia-YuanChia-YuanLinChiu, Hsiao-YeanHsiao-YeanChiuChen, Yang-ChingYang-ChingChen2022-06-272022-06-27202200260495https://scholars.lib.ntu.edu.tw/handle/123456789/613341Diabetes is an independent predictor of poor outcomes in patients with COVID-19. We compared the effects of the preadmission use of antidiabetic medications on the in-hospital mortality of patients with COVID-19 having type 2 diabetes.enAntidiabetic medication; COVID-19; Type 2 diabetes mellitus[SDGs]SDG3Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysisjournal article10.1016/j.metabol.2022.155196353674602-s2.0-85127481251https://scholars.lib.ntu.edu.tw/handle/123456789/604288